Eric M Ndombi

Dr. Eric M Ndombi

Medical Microbiology and Parasitology, Kenyatta University, Nairobi, Nairobi City, Kenya
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2018 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
BABernard O. Abudho
Bernard O. Abudho
ENEric M Ndombi
Eric M Ndombi
BGBernard Guya
Bernard Guya
JCJennifer M. Carter
Jennifer M. Carter
DRDiana K. Riner
Diana K. Riner
DCDaniel G. Colley
Daniel G. Colley
Schistosomiasis remains a major public health problem in Kenya. The World Health Organization recommends preventive chemotherapy with praziquantel (PZQ) to control morbidity due to schistosomiasis. Morbidity is considered linked to intensity of infection, which along with prevalence is used to determine the frequency of mass drug administration (MDA) to school-age children. We determined the impact of annual school-based MDA on children across all primary and high school years using a repeated cross-sectional study design in five schools near Lake Victoria in western Kenya, an area endemic for Schistosoma mansoni. At baseline and for the following four consecutive years, between 897 and 1,440 school children in Grades 1–12 were enrolled and evaluated by Kato-Katz for S. mansoni and soil-transmitted helminths (STH), followed by annual MDA with PZQ and albendazole. Four annual rounds of MDA with PZQ were associated with reduced S. mansoni prevalence in all school children (44.7–14.0%; P < 0.001) and mean intensity of infection by 91% (90.4 to 8.1 eggs per gram [epg] of stool; P < 0.001). Prevalence of high-intensity infection (≥ 400 epg) decreased from 6.8% at baseline to 0.3% by the end of the study. Soil-transmitted helminth infections, already low at baseline, also decreased significantly over the years. In this high prevalence area, annual school-based MDA with high coverage across all Grades (1–12) resulted in rapid and progressive declines in overall prevalence and intensity of infection. This decrease was dramatic in regard to heavy infections in older school-attending children.

6 June 2018 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
BOBartholomew N. Ondigo
Bartholomew N. Ondigo
ENEric M Ndombi
Eric M Ndombi
SNSarah C. Nicholson
Sarah C. Nicholson
JOJohn K. Oguso
John K. Oguso
JCJennifer M. Carter
Jennifer M. Carter
DCDaniel G. Colley
Daniel G. Colley
Immunoregulation is considered a common feature of Schistosoma mansoni infections, and elevated levels of T regulatory (Treg) lymphocytes have been reported during chronic human schistosomiasis. We now report that the removal of Treg (CD4+/CD25hi/CD127low lymphocytes) from peripheral blood mononuclear cells (PBMCs) of S. mansoni–infected individuals leads to increased levels of phytohemagglutinin (PHA)-stimulated interferon gamma (IFNγ) production and decreased interleukin-10 (IL-10) responses. Exposure to schistosome antigens did not result in measurable IFNγ by either PBMC or Treg-depleted populations. Interleukin-10 responses to soluble egg antigens (SEA) by PBMC were unchanged by Treg depletion, but the depletion of Treg greatly decreased IL-10 production to soluble worm antigenic preparation (SWAP). Proliferative responses to PHA increased upon Treg removal, but responses to SEA or SWAP did not, unless only initially low responders were evaluated. Addition of anti-IL-10 increased PBMC proliferative responses to either SEA or SWAP, but did not alter responses by Treg-depleted cells. Blockade by anti-transforming growth factor-beta (TGF-β) increased SEA but not SWAP proliferative responses by PBMC, whereas anti-TGF-β increased both SEA- and SWAP-stimulated responses by Treg-depleted cultures. Addition of both anti-IL-10 and anti-TGF-β to PBMC or Treg-depleted populations increased proliferation of both populations to either SEA or SWAP. These studies demonstrate that Treg appear to produce much of the antigen-stimulated IL-10, but other cell types or subsets of Treg may produce much of the TGF-β. The elevated levels of Treg seen in chronic schistosomiasis appear functional and involve IL-10 and TGF-β in antigen-specific immunoregulation perhaps leading to regulation of immunopathology and/or possibly decreased immunoprotective responses.

31 March 2018 in Parasite Immunology
Verified
Journal Article
Open access
PDF file
ENEric M Ndombi
Eric M Ndombi
BAB. Abudho
B. Abudho
NKN. Kittur
N. Kittur
JCJ. M. Carter
J. M. Carter
HKH. Korir
H. Korir
DCDaniel G. Colley
Daniel G. Colley
Summary: This study evaluated potential changes in antischistosome immune responses in children from schools that received 4 rounds of annual mass drug administration (MDA) of praziquantel (PZQ). In a repeated cross‐sectional study design, 210 schistosome egg‐positive children were recruited at baseline from schools in western Kenya (baseline group). Another 251 children of the same age range were recruited from the same schools and diagnosed with schistosome infection by microscopy (post‐MDA group). In‐vitro schistosome‐specific cytokines and plasma antibody levels were measured by ELISA and compared between the 2 groups of children. Schistosome soluble egg antigen (SEA) and soluble worm antigen preparation (SWAP) stimulated higher IL‐5 production by egg‐negative children in the post‐MDA group compared to the baseline group. Similarly, anti‐SEA IgE levels were higher in egg‐negative children in the post‐MDA group compared to the baseline group. Anti‐SEA and anti‐SWAP IgG4 levels were lower in egg‐negative children in the post‐MDA group compared to baseline. This resulted in higher anti‐SEA IgE/IgG4 ratios for children in the post‐MDA group compared to baseline. These post‐MDA immunological changes are compatible with the current paradigm that treatment shifts immune responses to higher antischistosome IgE:IgG4 ratios in parallel with a potential increase in resistance to reinfection.

18 March 2026 in International Journal for Parasitology: Drugs and Drug Resistance
Verified
Journal Article
Open access
CRClaudia M. Rohr
Claudia M. Rohr
SPSang-Kyu Park
Sang-Kyu Park
KAKelsilandia Aguiar-Martins
Kelsilandia Aguiar-Martins
TATimothy J.C. Anderson
Timothy J.C. Anderson
DBDuncan J. Berger
Duncan J. Berger
JMJonathan S. Marchant
Jonathan S. Marchant
The anthelmintic praziquantel (PZQ) has been used for decades as the clinical therapy for schistosomiasis, and remains the only available drug. As a cheap and effective drug therapy for all human disease-causing Schistosoma species, usage of PZQ underpins mass drug administration strategies aimed at eliminating schistosomiasis as a public health problem by 2030. Concern over the potential emergence of resistance to PZQ is therefore warranted, as it would constitute a major threat to this approach. In terms of molecular adaptations conferring PZQ resistance, variation in the sequence and/or expression of the drug target is an obvious mechanism and should be a priority for surveillance efforts. The target of PZQ is a transient receptor potential ion channel, TRPMPZQ, which is established as a locus that regulates schistosome sensitivity to PZQ. Here, we describe the establishment of a community resource, 'TRPtracker', which coalesces data on TRPMPZQ natural variants together with measurements of individual TRPMPZQ variant sensitivity to PZQ assessed by profiling TRPMPZQ in a heterologous expression system. A compendium of laboratory-generated mutants in TRPMPZQ is also compiled in the TRPtracker database to delimit regions within TRPMPZQ that are critical for PZQ sensitivity. Aggregation of data from multiple research groups into TRPtracker catalogues which TRPMPZQ variants have been functionally profiled, where geographically these variants have been found, their frequency within populations, and their potential impact on PZQ sensitivity. The overall goal is to facilitate rapid community-wide exchange of data to monitor predicted variants of concern that are likely to be associated with decreased PZQ efficacy.

Verified
Journal Article
Open access
PDF file
HKHarrison Korir
Harrison Korir
DRDiana K. Riner
Diana K. Riner
EKEmmy Kavere
Emmy Kavere
AOAmos Okil
Amos Okil
JLJasmine Landry
Jasmine Landry
DCDaniel G. Colley
Daniel G. Colley
Parasitologic surveys of young adults in college and university settings are not commonly done, even in areas known to be endemic for schistosomiasis and soil-transmitted helminths. We have done a survey of 291 students and staff at the Kisumu National Polytechnic in Kisumu, Kenya, using the stool microscopy Kato-Katz (KK) method and the urine point-of-care circulating cathodic antigen (POC-CCA) test. Based on three stools/two KK slides each, in the 208 participants for whom three consecutive stools were obtained, Schistosoma mansoni prevalence was 17.8%. When all 291 individuals were analyzed based on the first stool, as done by the national neglected tropical disease (NTD) program, and one urine POC-CCA assay (n = 276), the prevalence was 13.7% by KK and 23.2% by POC-CCA. Based on three stools, 2.5% of 208 participants had heavy S. mansoni infections (≥400 eggs/gram feces), with heavy S. mansoni infections making up 13.5% of the S. mansoni cases. The prevalence of the soil-transmitted helminths (STH: Ascaris lumbricoides, Trichuris trichiura and hookworm) by three stools was 1.4%, 3.1%, and 4.1%, respectively, and by the first stool was 1.4%, 2.4% and 1.4%, respectively. This prevalence and intensity of infection with S. mansoni in a college setting warrants mass drug administration with praziquantel. This population of young adults is ‘in school’ and is both approachable and worthy of inclusion in national schistosomiasis control and elimination programs.

3 May 2023
Verified
Book Chapter
Open access
PDF file
FMFestus Mulakoli
Festus Mulakoli
GGGeorge Gachara
George Gachara
ENEric M Ndombi
Eric M Ndombi
SKSamoel Khamadi
Samoel Khamadi
The provision of blood products to save a life is a noble undertaking for any organization tasked with the duty. In addition to saving millions of lives, blood products pose health risks associated with adverse events. Much has been done to mitigate these challenges, but emerging new infectious diseases pose a public health challenge to both the safety of blood and its availability. The dengue virus an arbovirus is one such virus that is endemic in tropical and subtropical countries. The data emerging from the published papers show that dengue could be a major threat to blood safety and availability in the future. To address these threats, a collaborative approach through one health system is the only avenue to provide a last solution. One health has been implemented as a strategy to mitigate zoonotic diseases and its results are very impressive. This piece of work is a fraction of our larger project that aims to address threats to the dengue virus and blood safety in Kenya and the rest of Africa. In conclusion, adopting one health in the fight against the dengue virus in blood safety will be the best approach to ensure a safer supply of blood products.